Research identifies links between high levels of blood clotting proteins and poorer breast cancer outcomes
In development: A synthetic foam that heals chronic wounds by suppressing inflammation and spurring blood vessel growth
30 June 2022Europe to see ‘high levels’ of COVID this summer: WHO
30 June 2022Research identifies links between high levels of blood clotting proteins and poorer breast cancer outcomes
New research from RCSI University of Medicine and Health Sciences has found that high levels in the bloodstream of a key protein involved in blood clotting called von Willebrand Factor, can lead to poorer outcomes for breast cancer patients. The findings will help researchers and doctors to better understand and treat breast cancer to reduce the risk of life-threatening blood clots and cancer spread in patients.
